Relapsed and Refractory Hematological Malignancies
1 clinical trials · Condition
◉ Watch Relapsed and Refractory Hematological Malignancies
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies (NCT04008524) | Institute of Hematology & Blood Diseases Hospital, China |
Track Relapsed and Refractory Hematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.